Northwestern Mutual Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-740
Closed -$85.6K 3744
2023
Q3
$85.6K Buy
740
+119
+19% +$12.8K ﹤0.01% 1770
2023
Q2
$63.9K Buy
621
+538
+648% +$56.8K ﹤0.01% 1894
2023
Q1
$9.06K Sell
83
-350
-81% -$38.7K ﹤0.01% 2539
2022
Q4
$49.3K Buy
433
+293
+209% +$24.3K ﹤0.01% 1919
2022
Q3
$8K Sell
140
-14
-9% -$978 ﹤0.01% 2557
2022
Q2
$11K Buy
154
+42
+38% +$3.98K ﹤0.01% 2493
2022
Q1
$12K Sell
112
-2,329
-95% -$227K ﹤0.01% 2487
2021
Q4
$263K Sell
2,441
-706
-22% -$77K ﹤0.01% 1319
2021
Q3
$344K Buy
3,147
+3,054
+3,284% +$317K ﹤0.01% 1136
2021
Q2
$9K Sell
93
-27
-23% -$2.48K ﹤0.01% 2492
2021
Q1
$11K Buy
120
+88
+275% +$7.43K ﹤0.01% 2268
2020
Q4
$3K Buy
+32
New +$2.38K ﹤0.01% 2498
2020
Q2
Sell
-55
Closed -$2K 2830
2020
Q1
$2K Buy
+55
New +$1.86K ﹤0.01% 2320
2019
Q3
Sell
-769
Closed -$19K 2821
2019
Q2
$19K Buy
769
+757
+6,308% +$19.2K ﹤0.01% 1755
2019
Q1
$0 Buy
+12
New +$284 ﹤0.01% 2780
2017
Q3
Sell
-1,550
Closed -$18K 2341
2017
Q2
$18K Buy
+1,550
New +$19.3K ﹤0.01% 1438
2017
Q1
Sell
-358
Closed -$6K 2582
2016
Q4
$6K Buy
+358
New +$6.49K ﹤0.01% 1814
2016
Q3
Sell
-549
Closed -$9K 1806
2016
Q2
$9K Sell
549
-56
-9% -$906 ﹤0.01% 1411
2016
Q1
$10K Buy
605
+604
+60,400% +$10.6K ﹤0.01% 1456
2015
Q4
$0 Buy
+1
New +$19 ﹤0.01% 1953
2015
Q3
Sell
-4
Closed 1914
2015
Q2
$0 Buy
+4
New +$122 ﹤0.01% 1717

Other funds holding HZNP

Northwestern Mutual Wealth Management's HZNP Position: Q4 2023 in Review

Northwestern Mutual Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 740 shares — an estimated $85.6K sold.

Northwestern Mutual Wealth Management first reported a position in HZNP in Q2 2015 and held it in 21 quarters. The position peaked at $344K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Northwestern Mutual Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 740 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $85.6K.
  • Northwestern Mutual Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 21 quarters.
  • Northwestern Mutual Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $344K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.